Can Zika virus antibodies cross-protect against dengue virus?

被引：5
|
作者：
Ribeiro, Guilherme S. [1 ,2 ]
Kikuti, Mariana [1 ,2 ]
Tauro, Laura B. [1 ]
Cardoso, Cristiane W. [3 ]
Paploski, Igor A. D. [1 ,2 ]
Ko, Albert I. [1 ,4 ]
Weaver, Scott C. [5 ]
Reis, Mitermayer G. [1 ,2 ]
Kitron, Uriel [1 ,6 ]
机构：
[1] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil
[2] Univ Fed Bahia, Salvador, BA, Brazil
[3] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil
[4] Yale Univ, New Haven, CT USA
[5] Univ Texas Med Branch, Galveston, TX 77555 USA
[6] Emory Univ, Atlanta, GA 30322 USA
来源：
LANCET GLOBAL HEALTH | 2018年 / 6卷 / 05期
关键词：
D O I：
10.1016/S2214-109X(18)30123-2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：E495 / E495
页数：1
相关论文
共 50 条
  • [31] Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
    Delgado, Felix G.
    Torres, Karina, I
    Castellanos, Jaime E.
    Romero-Sanchez, Consuelo
    Simon-Loriere, Etienne
    Sakuntabhai, Anavaj
    Roth, Claude
    VIRUSES-BASEL, 2018, 10 (09):
  • [32] Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
    Bailey, Mark J.
    Broecker, Felix
    Duehr, James
    Arumemi, Fortuna
    Krammer, Florian
    Palese, Peter
    Tan, Gene S.
    MBIO, 2019, 10 (02):
  • [33] The development of therapeutic antibodies against dengue virus
    Fibriansah, Guntur
    Lok, Shee-Mei
    ANTIVIRAL RESEARCH, 2016, 128 : 7 - 19
  • [34] Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Sootichote, Rochanawan
    Puangmanee, Wilarat
    Benjathummarak, Surachet
    Kowaboot, Siriporn
    Yamanaka, Atsushi
    Boonnak, Korbporn
    Ampawong, Sumate
    Chatchen, Supawat
    Ramasoota, Pongrama
    Pitaksajjakul, Pannamthip
    BIOMEDICINES, 2023, 11 (01)
  • [35] Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus
    Balasubramanian, Anuradha
    Teramoto, Tadahisa
    Kulkarni, Amol A.
    Bhattacharjee, Apurba K.
    Padmanabhan, Radhakrishnan
    ANTIVIRAL RESEARCH, 2017, 137 : 141 - 150
  • [36] Modified mRNA Vaccines Protect against Zika Virus Infection
    Richner, Justin M.
    Himansu, Sunny
    Dowd, Kimberly A.
    Butler, Scott L.
    Salazar, Vanessa
    Fox, Julie M.
    Julander, Justin G.
    Tang, William W.
    Shresta, Sujan
    Pierson, Theodore C.
    Ciaramella, Giuseppe
    Diamond, Michael S.
    CELL, 2017, 168 (06) : 1114 - +
  • [37] Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice
    Watanabe, Satoru
    Tan, Nicole Wei Wen
    Chan, Kitti Wing Ki
    Vasudevan, Subhash G.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (02): : 223 - 233
  • [38] Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil
    Pedroso, Celia
    Fischer, Carlo
    Feldmann, Marie
    Sarno, Manoel
    Luz, Estela
    Moreira-Soto, Andres
    Cabral, Renata
    Netto, Eduardo Martins
    Brites, Carlos
    Kummerer, Beate M.
    Drexler, Jan Felix
    EMERGING INFECTIOUS DISEASES, 2019, 25 (08) : 1485 - 1493
  • [39] Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection
    Lai, Yen-Chung
    Chuang, Yung-Chun
    Liu, Ching-Chuan
    Ho, Tzong-Shiann
    Lin, Yee-Shin
    Anderson, Robert
    Yeh, Trai-Ming
    SCIENTIFIC REPORTS, 2017, 7
  • [40] Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus
    Atitaya Hitakarun
    Sarawut Khongwichit
    Nitwara Wikan
    Sittiruk Roytrakul
    Sutee Yoksan
    Supoth Rajakam
    Andrew D. Davidson
    Duncan R. Smith
    Scientific Reports, 10
12345